Stoke Therapeutics, Inc. (STOK) — closed signal from September 29, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on December 28, 2025.
Predicted vs. what happened
What happened
Reached its target in 15 days.
The thesis — published September 29, 2025
STOK has been climbing steadily and recently hit prices near its yearly highs. News highlights an 82% jump in under two months, and recent drug approvals in neurology have lifted interest in this area. If the price dips toward its recent average price, that can offer a fresh entry for a 3 month trade. Biotech headlines can swing the stock, but with strong trend and active buyers, the move can continue.
Primary drivers
- Strong uptrend with steady buying interest and price strength near yearly highs
- Very upbeat attention from investors and media, boosting visibility and demand
- Biotech interest and this drug pipeline draw investors as key trial news nears
- Plan to buy dips during a strong climb, aiming for practical, lower-risk entries
How it played out
STOK: target reached in 15 days
Lyra published STOK at 24.33 on 2025-09-29 for a short-term window ending 2025-12-28. The thesis expected 35% growth toward 32.85. It pointed to a strong uptrend, steady buying interest, price strength near yearly highs, upbeat investor and media attention, biotech interest around the drug pipeline, and a plan to buy dips during a strong climb.
Inside the window, STOK reached the target in 15 days. The peak was 38.69 on 2025-10-16, with a peak gain of 59%. It ended the window at 31.92. The published thesis played out, and the move went beyond the target before settling below the peak.
What happened during the window
On 2025-12-16, Investor's Business Daily reported that Stoke had released third-quarter results on 2025-11-04. The report said revenue rose 117% year over year to $10.6 million, while the loss widened to $0.65 per share.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.